Wave Life Sciences’ (WVE) “Buy” Rating Reaffirmed at HC Wainwright
HC Wainwright reiterated their buy rating on shares of Wave Life Sciences (NASDAQ:WVE – Free Report) in a research note released on Wednesday,Benzinga reports. HC Wainwright currently has a $22.00 price objective on the stock. A number of other equities analysts have also recently commented on WVE. StockNews.com upgraded Wave Life Sciences from a “sell” […]
